Development of a New Isogenic Cell-Xenograft System for Evaluation of NAD(P)H:Quinone Oxidoreductase-Directed Antitumor Quinones: Evaluation of the Activity of RH1
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0411
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2004
Authors
Publisher
American Association for Cancer Research (AACR)